Search Results Search Sort by RelevanceMost Recent Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768. Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768.
Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.